Navigation Links
Novel Delivery Method of Insulin Gene to Combat Juvenile Diabetes Developed

A safer method to deliver the insulin gene to diabetes patients using nanoparticles, was presented today at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.

Type 1 or juvenile diabetes is caused by autoimmune destruction of the insulin producing pancreatic -cells. As a result of the loss of insulin, blood sugar levels rise too high, causing damage to fine blood vessels and nerve endings leading to debilitating symptoms. As a result patients become dependent upon daily insulin injections to survive. However, it is virtually impossible to match the sugar content of each meal with the optimal dose of insulin the cumulative mistakes severely reduce both the quality and length of life.

Recreating appropriately regulated internal insulin secretion in surrogate cells (i.e. non--cells) in individuals with diabetes is an attractive approach to cure this disease. A major hurdle with this approach has been replicating automatic insulin secretion that is tuned to the bodys requirements.

Dr. Anthony Cheung and his colleagues at enGene, Inc., Vancouver, aim to develop an approach to restore the meal-responsive insulin production and release capability in individuals with diabetes, thereby eliminating the need for insulin injections while also improving control of blood sugar levels.

They intend to achieve this by inducing specific cells of the gut to take over production of insulin. The team previously reported that gut K-cells can be induced with the insulin gene to produce insulin in response to meal ingestion in a pattern comparable to normal insulin production from the pancreas.

In order to translate this technology to clinical use, the team developed a novel method to deliver the insulin gene to the target K-cells in the gut using nanoparticles. The nanoparticles contain a component called chitosan that provides protection to the insulin gene while in the gut as well as
'"/>




Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
(Date:10/7/2008)... WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -- ...ecent winner of Dancing With the Stars, has been,n...ation Christmas Seals,Campaign in an effort to hel...sion: to prevent lung disease and promote lung hea...ls tradition began in 1907,to conquer Tuberculosis...
(Date:10/7/2008)...Less likely to feel distress, more likely to enjoy... TUESDAY, Oct. 7 (HealthDay News) -- End-of-life d...atient do not result in more distress for patients...interventions and enhanced quality of life in a pa... "For the past two decades, the debate has been ar...
(Date:10/7/2008)..., Surprise announcement of planned bequest comes .../PRNewswire-USNewswire/ -- Just over one year,ago,...million gift to the,University of Michigan, to end..., treating and preventing human disease., Today, ...n --,announcing that he will bequeath an additiona...
(Date:10/7/2008)...These brain-damaged individuals show signs of awar...AY, Oct. 7 (HealthDay News) -- Severely brain-dam... still feel pain and require painkilling treatment...ally conscious state (MCS) is different than a per...efulness without awareness of self or surroundings...
Breaking Medicine News(10 mins):Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Patients in Minimally Conscious State May Still Feel Pain 2
...bout one in three children in California is overwe...to statistics released by a health insurance compa... the Los Angeles County, which comprises 88 satell... overweight children in the county is about three ...
...close schools for up to three months in the event ...ould be canceled and working hours //staggered so ...vernment advised today in issuing new pandemic flu...h officials acknowledged that such measures would ...
On the 'Fast Buck' Trail: Kidneys on Sale
...ned from animals that are cloned will not bear any...s safe for consumption, there is no necessary to i... Press, the approval from the U.S. Government on c...s expected within a year. The Food and Drug Admini...
Other Medicine News:Health News:U.S. Issues Guidelines in Case of Flu Pandemic 2Health News:U.S. Issues Guidelines in Case of Flu Pandemic 3Health News:U.S. Issues Guidelines in Case of Flu Pandemic 4Health News:On the 'Fast Buck' Trail: Kidneys on Sale 2Health News:On the 'Fast Buck' Trail: Kidneys on Sale 3Health News:On the 'Fast Buck' Trail: Kidneys on Sale 4Health News:On the 'Fast Buck' Trail: Kidneys on Sale 5Health News:On the 'Fast Buck' Trail: Kidneys on Sale 6Health News:On the 'Fast Buck' Trail: Kidneys on Sale 7
(Date:10/7/2008)...tCall/ -- CEL-SCI Corporation,(NYSE: CVM ) announ...sfer,Agreement (MTA) with the National Institutes ...ry of Dr. Francesco M. Marincola, M.D., to,investi...icroenvironment,caused by CEL-SCI,s cancer drug Mu...ous Disease and Immunogentics Section, Department ...
(Date:10/7/2008).../ -- Aerovance Inc. today reported,pharmacokinetic...Aerovant,inhalation powder that demonstrate good t...llowing asthma patients, inhalation of a single 10... three doses investigated in,Aerovance,s Phase IIb...arly,next year. Evidence gathered from nonclinical...
(Date:10/7/2008)... Tests for Use on the GeneXpert(R) ...7 /- Cepheid (Nasdaq:,CPHD)...B as a European CE,IVD Mark product under the Euro...ces. The test delivers rapid detection of vanA and... with vancomycin-resistant,enterococci (VRE) -- on...
(Date:10/6/2008)...e/ -- "A return to the use of,chimpanzees in AIDS ...ific,justification," according to a paper released...nimals (ATLA). "An Assessment of the Role of,Chimp...ccine responses in,chimpanzees are not predictive ...zees, critical role and importance in AIDS vaccine...
Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 1Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 1University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 3Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 1Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 2Fruit and vegetables health 3210 1
...fety of Gene Therapy in Lipoprotein Lipase,Deficie... 31, 2007 - Amsterdam Molecular,Therapeutics (AMT)...orted positive Phase I/II clinical trial results w...MT-011) in Complete,Lipoprotein Lipase (LPL) defic...erican Society of Gene Therapy (ASGT) in Seattle.,...
...rom XL880, Phase II data from XL999 studies,schedu...-, SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-F...ata from clinical trials of,the company,s investig...d at the 2007 American Society of Clinical Oncolog...1 to 5 in Chicago,Illinois. , , -- Data from t...
Other Medicine Technology:AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2
...ontinuous low-flow nebulizer performance. Patented...allows for optimal medication and Heliox delivery ...vere asthma, COPD and pneumonia in both routine an... mouth and T-piece to deliver high-output, low-flo...
... diverse medical products for more than 58 years. ...anding reputation for innovation, quality and cust...ecognized brands include the Labtron® line of ... products, Bristoline® microscopes, HealthTeam...
...contains everything the health care professional n...ickly and efficiently: 7 nebulizers, T-piece and m...yringe and needle., ,Shipped 5 kits per case., ,...ed Use: AsthmaKit is a procedural kit providing th...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only
Medicine Products: